Please select the option that best describes you:

Topics: SarcomaMedical OncologyGIST

How do you approach non-surgical patients with GIST who are intolerant to imatinib 400 mg daily and unlikely to tolerate other TKIs?   

Do you reduce the dose to <400 mg daily or employ dosing schedules?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more